SCHEMBL7106296

SCHEMBL7106296

COc1c(-c2nccs2)ccc2[nH][c]nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 4/20 0.36
TUBB P07437 4/20 0.36
TUBA3C P0DPH7 4/20 0.36
TUBA1B P68363 4/20 0.36
TUBA4A P68366 4/20 0.36
TUBB4B P68371 4/20 0.36
TUBB3 Q13509 4/20 0.36
TUBB2A Q13885 4/20 0.36
TUBB8 Q3ZCM7 4/20 0.36
TUBA3E Q6PEY2 4/20 0.36
TUBA1A Q71U36 4/20 0.36
TUBA1C Q9BQE3 4/20 0.36
TUBB6 Q9BUF5 4/20 0.36
TUBB2B Q9BVA1 4/20 0.36
TUBB1 Q9H4B7 4/20 0.36
SMPD3 Q9NY59 1/20 0.34
CYP17A1 P05093 1/20 0.33
ECE1 P42892 1/20 0.32
TYK2 P29597 2/20 0.32
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810755 0.76 METAP1 (0.40) CYP17A1PDPK1GRM4METAP1ADRA1D
SCHEMBL7107739 0.75 ECE1 (0.35) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7448035 0.74 TUBB4A (0.36) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL26259808 0.74 SMPD3 (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10833235 0.70 KDM4E (0.36) ADRA1DADRA1AADRA1B
SCHEMBL7107793 0.70 MAPT (0.35) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL20092688 0.69 MGAM (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL2152304 0.67 GAA (0.54) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7108445 0.67 SMPD3 (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL17198695 0.67 CTSA (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MCCLURE KIM F (US) 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MMP1, MMP10, MMP3 TUBB4A 637/4885TUBB 281/4885TUBA3C 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.